INR 3.25
(4.84%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -3.74 Million INR | -59.95% |
2022 | -2.34 Million INR | 10.41% |
2021 | -2.61 Million INR | -1104.61% |
2020 | -217 Thousand INR | -75.0% |
2019 | -124 Thousand INR | 64.57% |
2018 | -350 Thousand INR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -8.31 Million INR | 0.0% |
2023 Q1 | -1.32 Million INR | 43.64% |
2023 FY | -3.74 Million INR | -59.95% |
2023 Q3 | -3.74 Million INR | -183.79% |
2023 Q4 | -3.74 Million INR | 0.0% |
2023 Q2 | -1.32 Million INR | 0.0% |
2022 Q1 | -63.28 Million INR | -2321.04% |
2022 FY | -2.34 Million INR | 10.41% |
2022 Q4 | -2.34 Million INR | 0.0% |
2022 Q3 | -2.34 Million INR | 96.3% |
2022 Q2 | -63.28 Million INR | 0.0% |
2021 Q1 | -47.19 Million INR | 0.0% |
2021 FY | -2.61 Million INR | -1104.61% |
2021 Q4 | -2.61 Million INR | 0.0% |
2021 Q3 | -2.61 Million INR | 94.46% |
2021 Q2 | -47.19 Million INR | 0.0% |
2020 FY | -217 Thousand INR | -75.0% |
2019 FY | -124 Thousand INR | 64.57% |
2018 FY | -350 Thousand INR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 3.86 Billion INR | 100.097% |
Aurobindo Pharma Limited | 3.69 Billion INR | 100.101% |
Glenmark Life Sciences Limited | -2.84 Billion INR | 99.868% |
Granules India Limited | 9.28 Billion INR | 100.04% |
Indoco Remedies Limited | 6.47 Billion INR | 100.058% |
Ajanta Pharma Limited | -954.9 Million INR | 99.608% |
Alkem Laboratories Limited | -1.6 Billion INR | 99.767% |
Alpa Laboratories Limited | 35.36 Million INR | 110.593% |
Brooks Laboratories Limited | 49.48 Million INR | 107.57% |
AstraZeneca Pharma India Limited | -5.01 Billion INR | 99.925% |
Bajaj HealthCare Limited | 3.29 Billion INR | 100.114% |
Bliss GVS Pharma Limited | -1.15 Billion INR | 99.676% |
Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 100.029% |
Eris Lifesciences Limited | 13.8 Billion INR | 100.027% |
FDC Limited | -57.75 Million INR | 93.514% |
Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 99.913% |
Gufic Biosciences Limited | 3.19 Billion INR | 100.117% |
Ind-Swift Laboratories Limited | -4.15 Billion INR | 99.91% |
Ipca Laboratories Limited | 11.41 Billion INR | 100.033% |
Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 99.73% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 100.194% |
Lasa Supergenerics Limited | 205.79 Million INR | 101.82% |
Laurus Labs Limited | 24.38 Billion INR | 100.015% |
Lupin Limited | 17.19 Billion INR | 100.022% |
Mankind Pharma Limited | -9.9 Billion INR | 99.962% |
Medicamen Biotech Limited | 160.31 Million INR | 102.337% |
Medico Remedies Limited | 78.67 Million INR | 104.761% |
Megasoft Limited | 1.28 Billion INR | 100.291% |
NATCO Pharma Limited | -5.81 Billion INR | 99.936% |
Piramal Pharma Limited | 42.27 Billion INR | 100.009% |
RPG Life Sciences Limited | -364.7 Million INR | 98.973% |
Sigachi Industries Limited | 859.94 Million INR | 100.436% |
Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 99.995% |
Suven Pharmaceuticals Limited | 144.97 Million INR | 102.584% |
Syncom Formulations (India) Limited | 46.21 Million INR | 108.106% |
Unichem Laboratories Limited | 931.91 Million INR | 100.402% |
Wanbury Limited | 1.1 Billion INR | 100.339% |
Windlas Biotech Limited | -273.04 Million INR | 98.628% |
ZIM Laboratories Limited | 983.6 Million INR | 100.381% |
Zydus Lifesciences Limited | 3.91 Billion INR | 100.096% |
Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 99.602% |
Divi's Laboratories Limited | -39.77 Billion INR | 99.991% |
Hester Biosciences Limited | 2.29 Billion INR | 100.164% |
Procter & Gamble Health Limited | -2.34 Billion INR | 99.84% |
Amrutanjan Health Care Limited | -248.79 Million INR | 98.494% |
Bal Pharma Limited | 1.26 Billion INR | 100.296% |
Strides Pharma Science Limited | 23.25 Billion INR | 100.016% |
Venus Remedies Limited | -267.7 Million INR | 98.601% |
Aarti Pharmalabs Limited | 2.61 Billion INR | 100.143% |
Nectar Lifesciences Limited | 6.15 Billion INR | 100.061% |
Shilpa Medicare Limited | 9.06 Billion INR | 100.041% |
Aarti Drugs Limited | 5.54 Billion INR | 100.068% |
IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 99.66% |
Suven Life Sciences Limited | -1.63 Billion INR | 99.771% |
Ind-Swift Limited | 9.5 Billion INR | 100.039% |
Valiant Laboratories Limited | -295.03 Million INR | 98.73% |
J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 100.133% |
Solara Active Pharma Sciences Limited | 10.02 Billion INR | 100.037% |
Themis Medicare Limited | 764.96 Million INR | 100.49% |
Hikal Limited | 7.96 Billion INR | 100.047% |
Torrent Pharmaceuticals Limited | 31.83 Billion INR | 100.012% |
Sequent Scientific Limited | 4.17 Billion INR | 100.09% |
Novartis India Limited | -5.89 Billion INR | 99.936% |
Wockhardt Limited | 18.27 Billion INR | 100.021% |
Jubilant Pharmova Limited | 27.07 Billion INR | 100.014% |
Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 79.692% |
Neuland Laboratories Limited | -214.05 Million INR | 98.25% |
Morepen Laboratories Limited | -231.17 Million INR | 98.38% |
Kilitch Drugs (India) Limited | 120.03 Million INR | 103.121% |
Mangalam Drugs & Organics Limited | 975.81 Million INR | 100.384% |